MyFinsight
Home
Blog
About
Back
Cash Flow
Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc. (ALDX)
source: myfinsight.com
Net decrease in cash
and cash...
-$19,912,519
(-49.88%↓ Y/Y)
Stock-based compensation
$1,643,001
(-32.12%↓ Y/Y)
Accrued expenses and
other liabilities
$168,630
(103.39%↑ Y/Y)
Depreciation and
amortization expense
$70,706
(-42.61%↓ Y/Y)
Net cash provided by
(used in) financing...
-$15,300,000
(-1625.71%↓ Y/Y)
Net cash used in
operating activities
-$4,589,422
(78.17%↑ Y/Y)
Net cash (used in)
provided by investing...
-$23,097
(-100.34%↓ Y/Y)
Canceled cashflow
$1,882,337
Repayment of long-term
debt
$15,000,000
Debt end of term
charge paid in cash
$300,000
Net loss
-$5,450,273
(72.33%↑ Y/Y)
Acquisitions of fixed assets
$23,097
Prepaid expenses and
other current assets
$1,017,606
(243.66%↑ Y/Y)
Accounts payable
-$3,880
(-100.46%↓ Y/Y)
Back